Search
Naltrexone Action Pathway
smpdb.ca/view/SMP0000687Drug actionNaltrexone (also known as ReVia and Vivitrol) is a competitive antagonist of mu-type opioid receptor in the central nervous system (CNS). Naltrexone is also a type of medication that are used for manage opioid or alcohol dependence. Bind...
Dihydromorphine Action Pathway
smpdb.ca/view/SMP0000689Drug actionDihydromorphine (also known as Paramorfan or Paramorphan) is analgesic that can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level of intra...
Ketobemidone Action Pathway
smpdb.ca/view/SMP0000690Drug actionKetobemidone (also known as Ketogan) is analgesic that can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level of intracellular cAMP by inhi...
Nalbuphine Action Pathway
smpdb.ca/view/SMP0000691Drug actionNalbuphine (also known as Rubuphine and Nubain) is a competitive antagonist of mu-type and kappa-type opioid receptor in the central nervous system (CNS). Nalbuphine is also a type of medication that are mainly used for treat pain. Bindi...
Methadyl Acetate Action Pathway
smpdb.ca/view/SMP0000678Drug actionMethadyl Acetate (also known as Acetylmethadol) is a synthetic opioid analgesic that can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level...
3-Methylthiofentanyl Action Pathway
smpdb.ca/view/SMP0000679Drug actionMethadyl Acetate (also known as Acetylmethadol) is analgesic that can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level of intracellular c...
Caffeine Cardiac Contraction Action Pathway
smpdb.ca/view/SMP0126520Drug actionThe antagonism of adenosine A1 receptors allows more norepinephrine to be released into the synapse where it causes contractions of the heart muscles through the norepinephrine subpathway. … Adenosine A1 receptors inhibit the release of catecholamines like norepinephrine from neurons that innervate the heart muscles.
Pseudoephedrine Action Pathway
smpdb.ca/view/SMP0125255Drug actionPseudoephedrine also inhibits sodium dependent noradrenaline receptors which prevents the reuptake of norepinephrine into the presynaptic neuron. … This causes norepinephrine to accumulate in the synapse which also activates alpha adrenergic receptors. These receptors then activate the Gq protein cascade.
Drugs: Ascorbic acid · Norepinephrine · Pseudoephedrine · Dopamine · Calcium · Magnesium cation +1 moreDroxidopa B2-Adrenergic Artery Dilation Action Pathway
smpdb.ca/view/SMP0126493Drug actionDroxidopa is an orally active synthetic precursor of norepinephrine that increases the deficient supply of norepinephrine in patients with NOH, thereby improving orthostatic blood pressure and alleviating … Norepinephrine binds to the beta-2 adrenergic receptor, the G protein signalling cascade begins.
Drugs: ATP · Norepinephrine · Potassium cation · Calcium · Magnesium cation · Cyclic adenosine monophosphatePhendimetrazine
go.drugbank.com/drugs/DB01579ApprovedIllicitPhendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances and in the US since 1970.